Abstract: The present invention relates to a monoclonal antibody or a fragment thereof specific to truncated Midkine (tMK) protein, hybridoma producing the monoclonal antibody, a method of detecting truncated Midkine protein (tMK) by use of the monoclonal antibody, a method of detecting a tumor cell, and a kit containing the monoclonal antibody for detecting truncated Midkine (tMK) protein.

Abstract: The present invention relates to a monoclonal antibody or a fragment thereof specific to truncated Midkine (tMK) protein, hybridoma producing the monoclonal antibody, a method of detecting truncated Midkine protein (tMK) by use of the monoclonal antibody, a method of detecting a tumor cell, and a kit containing the monoclonal antibody for detecting truncated Midkine (tMK) protein.

Abstract: A BLAST analysis unit calculates the homologies between data included in an analysis target data group and the first data group, respectively, and calculates the number of data exhibiting homologies (orthologous gene count) as a first homology value x by using the calculated values. This unit sets nA thresholds E and calculates a first homology value xi for each threshold Ei, and calculates the homologies between data included in the analysis target data group and the second data group, respectively. The unit calculates the number of data exhibiting homologies (orthologous gene count) as a second homology value y. The unit sets nB thresholds E and calculates a second homology value yi for each threshold Ei. A t-test unit determines to which one of the first and second data groups the analysis target data group is similar.

Abstract: A method of anticipating risk of the onset of cancer in an individual, including (1) obtaining a sample derived from the individual, (2) analyzing a polymorphism of a Midkine gene concerning the sample of (1), and (3) anticipating risk of the onset of cancer based on the polymorphism determined in (2) above.